Dr. Elizabeth Krakow

Claim this profile
Studies Myelodysplastic syndrome
Studies Granulocytic Leukemia
1 reported clinical trial
1 drug studied

Clinical Trials Elizabeth Krakow is currently running

Image of trial facility.

DR-18

for Leukemia

This phase I trial tests the safety, side effects and best dose of decoy-resistant interleukin-18 (DR-18) and how well it works in treating patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back after a period of improvement (relapsed) or that remains despite treatment (persistent) after hematopoietic cell transplantation (HCT). HCT is the only curative therapy for most forms of AML and MDS. However, relapse occurs in a third of patients and is the most common cause of death after HCT. DR-18, a variant of the human cytokine interleukin-18, binds to IL-18 binding probein (IL-18BP) and overcomes the inhibitory effect of the IL-18BP on IL-18, which may boost the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving DR-18 may be safe, tolerable and/or effective in treating patient with relapsed or persistent AML or MDS after HCT.
Recruiting1 award Phase 17 criteria

More about Elizabeth Krakow

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Elizabeth Krakow has experience with
  • Decoy-resistant Interleukin-18
Breakdown of trials Elizabeth Krakow has run
Myelodysplastic syndrome
Granulocytic Leukemia
Myelodysplastic Syndrome
Relapse
Acute Myeloid Leukemia

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth Krakow specialize in?
Elizabeth Krakow focuses on Myelodysplastic syndrome and Granulocytic Leukemia. In particular, much of their work with Myelodysplastic syndrome has involved treating patients, or patients who are undergoing treatment.
Is Elizabeth Krakow currently recruiting for clinical trials?
Yes, Elizabeth Krakow is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth Krakow has studied deeply?
Yes, Elizabeth Krakow has studied treatments such as Decoy-resistant interleukin-18.
What is the best way to schedule an appointment with Elizabeth Krakow?
Apply for one of the trials that Elizabeth Krakow is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top